Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$342M |
| 2 |
Intercontinental Exchange
ICE
|
+$284M |
| 3 |
Deere & Co
DE
|
+$255M |
| 4 |
Blackrock
BLK
|
+$248M |
| 5 |
Newmont
NEM
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$638M |
| 2 |
Alibaba
BABA
|
+$454M |
| 3 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$367M |
| 4 |
Pfizer
PFE
|
+$356M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$353M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.84% |
| 2 | Healthcare | 11.43% |
| 3 | Financials | 11.03% |
| 4 | Consumer Discretionary | 8.66% |
| 5 | Industrials | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CXO
2201
DELISTED
CONCHO RESOURCES INC.
CXO
| $5.18M | ﹤0.01% |
88,756
+5,550
| +7% | +$292K |
|
2202
Mercury Insurance
MCY
$5.93B
| $5.17M | ﹤0.01% |
99,145
-43,390
| -30% | -$1.94M |
|
|
BBT
2203
Beacon Financial Corp
BBT
$2.66B
| $5.17M | ﹤0.01% |
302,113
-25,506
| -8% | -$380K |
|
2204
Loews
L
$23.9B
| $5.17M | ﹤0.01% |
114,767
+6,360
| +6% | +$256K |
|
2205
Vanda Pharmaceuticals
VNDA
$307M
| $5.17M | ﹤0.01% |
393,306
-66,682
| -14% | -$803K |
|
2206
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.84B
| $5.17M | ﹤0.01% |
187,366
+3,204
| +2% | +$87.5K |
|
2207
Mueller Water Products
MWA
$3.95B
| $5.16M | ﹤0.01% |
417,140
-2,276
| -0.5% | -$26.2K |
|
2208
Spero Therapeutics
SPRO
$67.7M
| $5.15M | ﹤0.01% |
+265,441
| New | +$4.14M |
|
2209
Legacy Housing
LEGH
$625M
| $5.14M | ﹤0.01% |
340,486
+22,400
| +7% | +$329K |
|
2210
iShares Core Moderate Allocation ETF
AOM
$1.74B
| $5.14M | ﹤0.01% |
118,891
-1,454
| -1% | -$61.2K |
|
2211
Invesco Variable Rate Preferred ETF
VRP
$2.98B
| $5.14M | ﹤0.01% |
197,857
-11,661
| -6% | -$295K |
|
2212
Smith & Nephew
SNN
$13.3B
| $5.13M | ﹤0.01% |
121,583
+41,119
| +51% | +$1.63M |
|
2213
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.2B
| $5.12M | ﹤0.01% |
42,725
+388
| +0.9% | +$43.9K |
|
2214
iShares Morningstar Small-Cap Value ETF
ISCV
$692M
| $5.11M | ﹤0.01% |
108,729
-15,696
| -13% | -$659K |
|
|
PGTI
2215
DELISTED
PGT, Inc.
PGTI
| $5.1M | ﹤0.01% |
250,840
-11,728
| -4% | -$218K |
|
2216
Outfront Media
OUT
$5.61B
| $5.1M | ﹤0.01% |
264,617
-7,257
| -3% | -$123K |
|
|
ECOL
2217
DELISTED
US Ecology, Inc.
ECOL
| $5.1M | ﹤0.01% |
140,297
+2,913
| +2% | +$101K |
|
2218
Veeco
VECO
$3.05B
| $5.09M | ﹤0.01% |
293,233
+17,048
| +6% | +$261K |
|
|
EGRX
2219
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.08M | ﹤0.01% |
109,127
+2,935
| +3% | +$137K |
|
2220
TripAdvisor
TRIP
$1.65B
| $5.08M | ﹤0.01% |
176,358
-10,442
| -6% | -$251K |
|
2221
ProShares Investment Grade-Interest Rate Hedged
IGHG
$330M
| $5.08M | ﹤0.01% |
67,245
-82,286
| -55% | -$6.09M |
|
|
TRST
2222
Trustco Bank Corp NY
TRST
$970M
| $5.07M | ﹤0.01% |
151,954
+987
| +0.7% | +$29.7K |
|
2223
Allegion
ALLE
$13.4B
| $5.07M | ﹤0.01% |
43,537
-660,466
| -94% | -$71.8M |
|
2224
State Street SPDR NYSE Technology ETF
XNTK
$2.06B
| $5.07M | ﹤0.01% |
35,802
-23,633
| -40% | -$3.03M |
|
2225
Archrock
AROC
$6.27B
| $5.06M | ﹤0.01% |
584,480
-19,431
| -3% | -$142K |
|
Similar funds
Ameriprise's Q4 2020 Portfolio in Review
As of Q4 2020, Ameriprise held 3,918 positions worth $282B, up 15% from $246B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Ameriprise's Q4 2020 filing shows 198 new, 1,664 increased, 1,807 reduced and 165 closed positions. Its largest new stake was Array Technologies: 1,865,836 shares worth $80.5M. The largest sale was Apple, an estimated $638M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q4 2020 buy was Array Technologies: 1,865,836 shares worth $80.5M.
- Ameriprise added most to Morgan Stanley in Q4 2020, an estimated $342M increase.
- Ameriprise's biggest Q4 2020 reduction was Apple, cutting an estimated $638M.
- Ameriprise fully exited Immunomedics Inc in Q4 2020, selling an estimated $149M.
- Ameriprise's ten largest holdings make up 16% of its $282B portfolio in Q4 2020.
- Ameriprise opened 198 new positions and closed 165 in Q4 2020.
- Ameriprise's portfolio value rose 15% quarter-over-quarter to $282B.
Based on Ameriprise's 13F filing for Q4 2020, filed 12 Feb 2021.